Scientific Presentations Scientific Presentations ACAAI Poster 2024 BP Safety Cardiovascular Safety of Intramuscular and Intranasal Epinephrine Administration 831.2 KB ACAAI Poster 2024 EPI 18 Pharmacokinetics and Pharmacodynamics Following Repeat Dosing of neffy, Epinephrine Nasal Spray, Versus Intramuscular Injection During Induced Allergic Rhinitis 952.1 KB ACAAI Poster 2024 PK Profiles Significant Differences in Pharmacokinetic Profiles Among Epinephrine Products – What is the Mechanism for Efficacy? 579.6 KB AAAAI 2024 Phase 2 Urticaria Results ARS-2 (neffy), Low-Dose Intranasal Epinephrine, Improves Urticaria Scores in Patients with Frequent Urticaria Flares: Phase 2 Study Results 567.4 KB AAAAI 2024 Poster CMC Comparative Stability of Three Epinephrine Products Under Extreme Temperature Conditions 514.3 KB AAAAI 2024 Poster EPI 10 Pediatric Doses of neffy (epinephrine nasal spray) Demonstrate Pharmacokinetic Profiles Equivalent to Epinephrine Injection Products 649 KB AAAAI 2024 Poster EPI JP03 neffy, Epinephrine Nasal Spray, Demonstrates a Positive Efficacy and Safety Profile for the Treatment of Allergic Reactions in Pediatric Patients at Risk of Anaphylaxis: Phase 3 Study Results 670.9 KB AAAAI 2024 Quality of Life Effect of Needle-Free Epinephrine on Food Allergy Patient and Caregiver Quality of Life 1 MB AAAAI 2024 Epinephrine Utilization A Survey of Allergists, Pediatricians, and Primary Care Physicians About the Utilization of Epinephrine 1.1 MB ACAAI 2023 Poster 7 Acute Allergic Rhinitis Increases Endogenous Epinephrine Resulting in Increased Heart Rate 678.5 KB Pagination First page « first Previous page ‹ previous Page 1 Current page 2 Page 3 Next page next › Last page last »
Scientific Presentations ACAAI Poster 2024 BP Safety Cardiovascular Safety of Intramuscular and Intranasal Epinephrine Administration 831.2 KB ACAAI Poster 2024 EPI 18 Pharmacokinetics and Pharmacodynamics Following Repeat Dosing of neffy, Epinephrine Nasal Spray, Versus Intramuscular Injection During Induced Allergic Rhinitis 952.1 KB ACAAI Poster 2024 PK Profiles Significant Differences in Pharmacokinetic Profiles Among Epinephrine Products – What is the Mechanism for Efficacy? 579.6 KB AAAAI 2024 Phase 2 Urticaria Results ARS-2 (neffy), Low-Dose Intranasal Epinephrine, Improves Urticaria Scores in Patients with Frequent Urticaria Flares: Phase 2 Study Results 567.4 KB AAAAI 2024 Poster CMC Comparative Stability of Three Epinephrine Products Under Extreme Temperature Conditions 514.3 KB AAAAI 2024 Poster EPI 10 Pediatric Doses of neffy (epinephrine nasal spray) Demonstrate Pharmacokinetic Profiles Equivalent to Epinephrine Injection Products 649 KB AAAAI 2024 Poster EPI JP03 neffy, Epinephrine Nasal Spray, Demonstrates a Positive Efficacy and Safety Profile for the Treatment of Allergic Reactions in Pediatric Patients at Risk of Anaphylaxis: Phase 3 Study Results 670.9 KB AAAAI 2024 Quality of Life Effect of Needle-Free Epinephrine on Food Allergy Patient and Caregiver Quality of Life 1 MB AAAAI 2024 Epinephrine Utilization A Survey of Allergists, Pediatricians, and Primary Care Physicians About the Utilization of Epinephrine 1.1 MB ACAAI 2023 Poster 7 Acute Allergic Rhinitis Increases Endogenous Epinephrine Resulting in Increased Heart Rate 678.5 KB Pagination First page « first Previous page ‹ previous Page 1 Current page 2 Page 3 Next page next › Last page last »
Pharmacokinetics and Pharmacodynamics Following Repeat Dosing of neffy, Epinephrine Nasal Spray, Versus Intramuscular Injection During Induced Allergic Rhinitis 952.1 KB
Significant Differences in Pharmacokinetic Profiles Among Epinephrine Products – What is the Mechanism for Efficacy? 579.6 KB
ARS-2 (neffy), Low-Dose Intranasal Epinephrine, Improves Urticaria Scores in Patients with Frequent Urticaria Flares: Phase 2 Study Results 567.4 KB
Pediatric Doses of neffy (epinephrine nasal spray) Demonstrate Pharmacokinetic Profiles Equivalent to Epinephrine Injection Products 649 KB
neffy, Epinephrine Nasal Spray, Demonstrates a Positive Efficacy and Safety Profile for the Treatment of Allergic Reactions in Pediatric Patients at Risk of Anaphylaxis: Phase 3 Study Results 670.9 KB
A Survey of Allergists, Pediatricians, and Primary Care Physicians About the Utilization of Epinephrine 1.1 MB